Scott Mullaney

2.8k total citations
15 papers, 435 citations indexed

About

Scott Mullaney is a scholar working on Nephrology, Infectious Diseases and Virology. According to data from OpenAlex, Scott Mullaney has authored 15 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 3 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Scott Mullaney's work include HIV Research and Treatment (3 papers), Dialysis and Renal Disease Management (3 papers) and Virus-based gene therapy research (2 papers). Scott Mullaney is often cited by papers focused on HIV Research and Treatment (3 papers), Dialysis and Renal Disease Management (3 papers) and Virus-based gene therapy research (2 papers). Scott Mullaney collaborates with scholars based in United States and Canada. Scott Mullaney's co-authors include Ravindra L. Mehta, David C. Mendelssohn, Ruth M. Ruprecht, Robert W. Finberg, Roderick T. Bronson, Miguel A. Sosa, Julie Andersen, Albert Chiu, Meenakshi Bhalla and Vikas Bhalla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Journal of the American Society of Nephrology.

In The Last Decade

Scott Mullaney

14 papers receiving 419 citations

Peers

Scott Mullaney
Ka‐Foon Chau China
Michel Ntetani Aloni Democratic Republic of the Congo
Vivek Chauhan India
Paddy McMaster United Kingdom
Cheryl Denski United States
Sandrine Vinault France
D. BenEzra United States
Peter Barclay Australia
Taylor Kain Canada
Ifeoma Anochie Nigeria
Ka‐Foon Chau China
Scott Mullaney
Citations per year, relative to Scott Mullaney Scott Mullaney (= 1×) peers Ka‐Foon Chau

Countries citing papers authored by Scott Mullaney

Since Specialization
Citations

This map shows the geographic impact of Scott Mullaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Mullaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Mullaney more than expected).

Fields of papers citing papers by Scott Mullaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Mullaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Mullaney. The network helps show where Scott Mullaney may publish in the future.

Co-authorship network of co-authors of Scott Mullaney

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Mullaney. A scholar is included among the top collaborators of Scott Mullaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Mullaney. Scott Mullaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mullaney, Scott, et al.. (2024). Feline Footprints in Transplant Realms. Journal of the American Society of Nephrology. 35(10S).
2.
Mullaney, Scott. (2022). Vancomycin Should Be Considered a Nephrotoxic Antimicrobial Agent: CON. Kidney360. 3(9). 1488–1490. 2 indexed citations
3.
Mullaney, Scott, et al.. (2012). Quiz Page May 2012. American Journal of Kidney Diseases. 59(5). A27–A29. 1 indexed citations
4.
Sheen, Victoria, Vikas Bhalla, Meenakshi Bhalla, et al.. (2007). The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. American Heart Journal. 153(2). 244.e1–244.e5. 50 indexed citations
5.
Fitzgerald, Robert L., D. J. Hillegonds, Douglas W. Burton, et al.. (2005). 41Ca and Accelerator Mass Spectrometry to Monitor Calcium Metabolism in End Stage Renal Disease Patients. Clinical Chemistry. 51(11). 2095–2102. 22 indexed citations
6.
Sheen, Victoria, Vikas Bhalla, Meenakshi Bhalla, et al.. (2004). The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease (ESRD). Journal of Cardiac Failure. 10(4). S46–S46. 1 indexed citations
7.
Arbab‐Zadeh, Armin, Ravindra L. Mehta, Thomas W. Ziegler, et al.. (2002). Hemodialysis access assessment with intravascular ultrasound. American Journal of Kidney Diseases. 39(4). 813–823. 17 indexed citations
8.
Mendelssohn, David C., et al.. (2001). What Do American Nephrologists Think About Dialysis Modality Selection?. American Journal of Kidney Diseases. 37(1). 22–29. 8 indexed citations
9.
Mendelssohn, David C., et al.. (2001). What do American nephrologists think about dialysis modality selection?. American Journal of Kidney Diseases. 37(1). 22–29. 164 indexed citations
10.
Ruprecht, Ruth M., et al.. (1991). Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivo.. PubMed. 4(1). 48–55. 12 indexed citations
11.
Finberg, Robert W., et al.. (1991). Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells. Journal of Virology. 65(1). 220–224. 44 indexed citations
12.
Fazely, F, et al.. (1990). Murine models for evaluating antiretroviral therapy.. PubMed. 50(17 Suppl). 5618S–5627S. 11 indexed citations
13.
Chou, Ting‐Chao, et al.. (1990). Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure.. PubMed. 3(6). 591–600. 37 indexed citations
14.
Ruprecht, Ruth M., et al.. (1990). Vaccination with a live retrovirus: the nature of the protective immune response.. Proceedings of the National Academy of Sciences. 87(14). 5558–5562. 33 indexed citations
15.
Ruprecht, Ruth M., Scott Mullaney, Julie Andersen, & Roderick T. Bronson. (1989). In vivo analysis of castanospermine, a candidate antiretroviral agent.. PubMed. 2(2). 149–57. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ka‐Foon Chau Breakdown of academic impact, for papers by Michel Ntetani Aloni Breakdown of academic impact, for papers by Vivek Chauhan Breakdown of academic impact, for papers by Paddy McMaster Breakdown of academic impact, for papers by Cheryl Denski Breakdown of academic impact, for papers by Sandrine Vinault Breakdown of academic impact, for papers by D. BenEzra Breakdown of academic impact, for papers by Peter Barclay Breakdown of academic impact, for papers by Taylor Kain Breakdown of academic impact, for papers by Ifeoma Anochie
Rankless by CCL
2026